id	sid	eid	entity	type
ijpds-4564	1	1	3	CARDINAL
ijpds-4564	1	2	2 | apr –	TIME
ijpds-4564	1	3	2024	CARDINAL
ijpds-4564	1	4	indian	NORP
ijpds-4564	1	5	j pharm drug	PRODUCT
ijpds-4564	1	6	46	CARDINAL
ijpds-4564	1	7	sukumar saralaya	PERSON
ijpds-4564	1	8	sri dharmasthala manjunatheshwara institute of technology	GPE
ijpds-4564	1	9	sdm	ORG
ijpds-4564	2	1	belthangady taluk	PERSON
ijpds-4564	2	2	dakshina kannada	PERSON
ijpds-4564	2	3	karnataka	GPE
ijpds-4564	2	4	india	GPE
ijpds-4564	5	1	propargyl part/	NORP
ijpds-4564	11	1	1	CARDINAL
ijpds-4564	11	2	2	CARDINAL
ijpds-4564	12	1	azipron®	ORG
ijpds-4564	12	2	3	CARDINAL
ijpds-4564	14	1	4	CARDINAL
ijpds-4564	15	1	1h	CARDINAL
ijpds-4564	15	2	267.34	CARDINAL
ijpds-4564	16	1	7	CARDINAL
ijpds-4564	16	2	8	CARDINAL
ijpds-4564	17	1	agn-1135	DATE
ijpds-4564	17	2	n-2-propynyll-indanamine-hydrochloride	ORG
ijpds-4564	17	3	9	CARDINAL
ijpds-4564	17	4	10	CARDINAL
ijpds-4564	19	1	29th	DATE
ijpds-4564	19	2	2024	DATE
ijpds-4564	19	3	04th	ORDINAL
ijpds-4564	19	4	2024	DATE
ijpds-4564	19	5	07th may	DATE
ijpds-4564	19	6	2024	CARDINAL
ijpds-4564	20	1	11	CARDINAL
ijpds-4564	22	1	united states	GPE
ijpds-4564	22	2	12	CARDINAL
ijpds-4564	22	3	13	CARDINAL
ijpds-4564	23	1	lawson wb & rao gjs	ORG
ijpds-4564	23	2	1	CARDINAL
ijpds-4564	23	3	2,3-dihydro-1h-inden-1-amine	QUANTITY
ijpds-4564	23	4	1	CARDINAL
ijpds-4564	23	5	2	CARDINAL
ijpds-4564	23	6	2	CARDINAL
ijpds-4564	23	7	14	CARDINAL
ijpds-4564	23	8	15	CARDINAL
ijpds-4564	24	1	nh ch h nh ch h s	ORG
ijpds-4564	26	1	ch3	NORP
ijpds-4564	26	2	1	CARDINAL
ijpds-4564	76	1	sdm	ORG
ijpds-4564	76	2	siddhavana gurukula	PERSON
ijpds-4564	76	3	belthangady taluk	PERSON
ijpds-4564	76	4	dakshina kannada	PERSON
ijpds-4564	76	5	karnataka	GPE
ijpds-4564	76	6	india	GPE
ijpds-4564	76	7	sanjayss@sdmit.in	TIME
ijpds-4564	76	8	mailto:sanjayss@sdmit.in	ORG
ijpds-4564	76	9	3	CARDINAL
ijpds-4564	76	10	2 | apr –	TIME
ijpds-4564	76	11	2024	CARDINAL
ijpds-4564	76	12	indian	NORP
ijpds-4564	76	13	j pharm drug	PRODUCT
ijpds-4564	76	14	47	CARDINAL
ijpds-4564	78	1	2	CARDINAL
ijpds-4564	78	2	2	CARDINAL
ijpds-4564	78	3	1	CARDINAL
ijpds-4564	78	4	2	CARDINAL
ijpds-4564	78	5	maruyama w &	ORG
ijpds-4564	78	6	1s)-n-(prop-2	CARDINAL
ijpds-4564	78	7	3	CARDINAL
ijpds-4564	80	1	16	CARDINAL
ijpds-4564	80	2	17	CARDINAL
ijpds-4564	81	1	3	CARDINAL
ijpds-4564	81	2	3	CARDINAL
ijpds-4564	81	3	1	CARDINAL
ijpds-4564	81	4	4	CARDINAL
ijpds-4564	81	5	1	CARDINAL
ijpds-4564	81	6	5	CARDINAL
ijpds-4564	81	7	6	CARDINAL
ijpds-4564	81	8	18	CARDINAL
ijpds-4564	82	1	ch nh2 ch3	PERSON
ijpds-4564	82	2	4 5	CARDINAL
ijpds-4564	82	3	nh ch3	NORP
ijpds-4564	82	4	6 +	DATE
ijpds-4564	82	5	1	CARDINAL
ijpds-4564	82	6	4	CARDINAL
ijpds-4564	82	7	rasagiline & selegiline	ORG
ijpds-4564	82	8	youdim mbh &	ORG
ijpds-4564	82	9	three	CARDINAL
ijpds-4564	82	10	3r)-3-(prop-2-yn-1-ylamino)-2,3dihydro-1h-inden-5-yl	DATE
ijpds-4564	82	11	7	CARDINAL
ijpds-4564	82	12	3s)-3(prop-2-yn-1-ylamino)-2,3	DATE
ijpds-4564	82	13	8	CARDINAL
ijpds-4564	82	14	3-[(1r)-1-(dimethylamino	CARDINAL
ijpds-4564	82	15	3-dihydro-1h	QUANTITY
ijpds-4564	82	16	9	CARDINAL
ijpds-4564	83	1	19	CARDINAL
ijpds-4564	84	1	20	CARDINAL
ijpds-4564	85	1	o	DATE
ijpds-4564	85	2	7	CARDINAL
ijpds-4564	85	3	o	DATE
ijpds-4564	85	4	8	CARDINAL
ijpds-4564	85	5	ch3 ch3 n ch3 ch3	PERSON
ijpds-4564	85	6	9	CARDINAL
ijpds-4564	85	7	5	CARDINAL
ijpds-4564	85	8	18	CARDINAL
ijpds-4564	85	9	maruyama w &	ORG
ijpds-4564	85	10	four	CARDINAL
ijpds-4564	85	11	2r)n-methyl-n-(prop-2-yn-1-yl)heptan-2-amine	TIME
ijpds-4564	85	12	10	CARDINAL
ijpds-4564	85	13	2s)-nmethyl-n-(prop-2-yn-1-yl)heptan-2-amine 11	QUANTITY
ijpds-4564	85	14	2r)-n-(prop2	CARDINAL
ijpds-4564	85	15	12	CARDINAL
ijpds-4564	85	16	3-[(2r)-heptan-2ylamino]propanoic	CARDINAL
ijpds-4564	85	17	13	CARDINAL
ijpds-4564	86	1	21	CARDINAL
ijpds-4564	87	1	yu ph &	ORG
ijpds-4564	87	2	22	CARDINAL
ijpds-4564	87	3	berry md & boulton aa	ORG
ijpds-4564	88	1	23	CARDINAL
ijpds-4564	89	1	ch3 n ch3 ch3 ch ch3 n ch3 ch3 ch ch3 n	PERSON
ijpds-4564	91	1	6	CARDINAL
ijpds-4564	91	2	21	CARDINAL
ijpds-4564	92	1	24	CARDINAL
ijpds-4564	93	1	maruyama w &	ORG
ijpds-4564	93	2	7, 8, 9	DATE
ijpds-4564	93	3	3r)3-(prop-2-yn-1-ylamino)-2,3	DATE
ijpds-4564	93	4	2,3-dihydro-1h	QUANTITY
ijpds-4564	93	5	15	DATE
ijpds-4564	95	1	7 & 8	ORG
ijpds-4564	96	1	netanya	ORG
ijpds-4564	96	2	israel	GPE
ijpds-4564	97	1	25	CARDINAL
ijpds-4564	99	1	oh 14	DATE
ijpds-4564	99	2	15	CARDINAL
ijpds-4564	99	3	7	CARDINAL
ijpds-4564	99	4	25	CARDINAL
ijpds-4564	99	5	7 & 8	DATE
ijpds-4564	99	6	26	CARDINAL
ijpds-4564	100	1	j & coworkers	ORG
ijpds-4564	100	2	27	CARDINAL
ijpds-4564	101	1	binda c & coworkers	ORG
ijpds-4564	101	2	four	CARDINAL
ijpds-4564	101	3	3	CARDINAL
ijpds-4564	102	1	2 | apr –	TIME
ijpds-4564	102	2	2024	CARDINAL
ijpds-4564	102	3	indian	NORP
ijpds-4564	102	4	j pharm drug	PRODUCT
ijpds-4564	102	5	48	CARDINAL
ijpds-4564	102	6	3	CARDINAL
ijpds-4564	102	7	13	DATE
ijpds-4564	102	8	1r)-n-methyl-n-(prop-2-yn-1-yl)-2,3-dihydro1h-inden-1-amine	QUANTITY
ijpds-4564	102	9	16	CARDINAL
ijpds-4564	102	10	28	CARDINAL
ijpds-4564	103	1	16	CARDINAL
ijpds-4564	103	2	8	CARDINAL
ijpds-4564	103	3	28	CARDINAL
ijpds-4564	104	1	hubálek f & coworkers	ORG
ijpds-4564	104	2	five	CARDINAL
ijpds-4564	104	3	3	CARDINAL
ijpds-4564	104	4	11	DATE
ijpds-4564	104	5	13 & 16	DATE
ijpds-4564	105	1	3	CARDINAL
ijpds-4564	105	2	2500-fold	CARDINAL
ijpds-4564	105	3	17-fold	CARDINAL
ijpds-4564	105	4	29	CARDINAL
ijpds-4564	106	1	s & coworkers	ORG
ijpds-4564	106	2	als	ORG
ijpds-4564	107	1	30	CARDINAL
ijpds-4564	108	1	7 & 8	DATE
ijpds-4564	110	1	32	CARDINAL
ijpds-4564	110	2	33	CARDINAL
ijpds-4564	111	1	34	CARDINAL
ijpds-4564	112	1	35	CARDINAL
ijpds-4564	113	1	ch3 ch3 n ch3 ch	PERSON
ijpds-4564	114	1	o	DATE
ijpds-4564	114	2	n ch3 ch3 nh ch nh2 nh ch3 nh ch3	ORG
ijpds-4564	114	3	o	DATE
ijpds-4564	114	4	ch3 ch3 n ch3 ch	PERSON
ijpds-4564	114	5	17	CARDINAL
ijpds-4564	114	6	1-s	QUANTITY
ijpds-4564	114	7	19	CARDINAL
ijpds-4564	114	8	nh2 nh ch	PRODUCT
ijpds-4564	115	1	oh 22	DATE
ijpds-4564	115	2	9	CARDINAL
ijpds-4564	115	3	36	CARDINAL
ijpds-4564	116	1	binda c & coworkers	ORG
ijpds-4564	118	1	1	CARDINAL
ijpds-4564	118	2	1-s	QUANTITY
ijpds-4564	118	3	1r)-1-[methyl(prop-2yn-1	ORDINAL
ijpds-4564	118	4	17	DATE
ijpds-4564	118	5	1r)-1-(prop-2-yn-1-ylamino)2,3-dihydro-1h-inden-4-yl	DATE
ijpds-4564	118	6	18	DATE
ijpds-4564	118	7	1r)n-methyl-2,3-dihydro-1h-inden-1-amine 19	DATE
ijpds-4564	118	8	1s)-n-methyl2,3-dihydro-1h-inden-1-amine 20	MONEY
ijpds-4564	118	9	3r)-3-[methyl(prop-2-yn1	DATE
ijpds-4564	118	10	21	DATE
ijpds-4564	118	11	1r)-1-(prop-2-yn-1-ylamino)2,3-dihydro-1h-inden-4-ol 22	DATE
ijpds-4564	119	1	36	CARDINAL
ijpds-4564	120	1	37	CARDINAL
ijpds-4564	121	1	oldfield v & coworkers	ORG
ijpds-4564	121	2	38	CARDINAL
ijpds-4564	122	1	gallagher da &	ORG
ijpds-4564	123	1	one	CARDINAL
ijpds-4564	124	1	one	CARDINAL
ijpds-4564	125	1	39	CARDINAL
ijpds-4564	126	1	23	CARDINAL
ijpds-4564	127	1	23	CARDINAL
ijpds-4564	127	2	4	CARDINAL
ijpds-4564	127	3	24	CARDINAL
ijpds-4564	127	4	1r)-2,3	CARDINAL
ijpds-4564	127	5	4-methylbenzenesulfonate	QUANTITY
ijpds-4564	127	6	25	CARDINAL
ijpds-4564	128	1	26	CARDINAL
ijpds-4564	128	2	kh2po4	PERSON
ijpds-4564	129	1	methanesulfonic	NORP
ijpds-4564	130	1	40	CARDINAL
ijpds-4564	132	1	ch3 toluene	ORG
ijpds-4564	133	1	2o	CARDINAL
ijpds-4564	133	2	o	DATE
ijpds-4564	133	3	ch3 ch nh2 .hcl kh2po4	PERSON
ijpds-4564	133	4	toluene ipa	ORG
ijpds-4564	133	5	92.0%	PERCENT
ijpds-4564	133	6	79.0%	PERCENT
ijpds-4564	133	7	1	CARDINAL
ijpds-4564	133	8	23	CARDINAL
ijpds-4564	133	9	40	CARDINAL
ijpds-4564	134	1	3	CARDINAL
ijpds-4564	134	2	2 | apr –	TIME
ijpds-4564	134	3	2024	CARDINAL
ijpds-4564	134	4	indian	NORP
ijpds-4564	134	5	j pharm drug	PRODUCT
ijpds-4564	134	6	49	CARDINAL
ijpds-4564	134	7	3	CARDINAL
ijpds-4564	135	1	kapubalu sk &	ORG
ijpds-4564	135	2	one	CARDINAL
ijpds-4564	135	3	3	CARDINAL
ijpds-4564	136	1	3	CARDINAL
ijpds-4564	136	2	800c	PRODUCT
ijpds-4564	137	1	2	CARDINAL
ijpds-4564	139	1	41	CARDINAL
ijpds-4564	140	1	first	ORDINAL
ijpds-4564	140	2	gittos mw &	ORG
ijpds-4564	141	1	42	CARDINAL
ijpds-4564	142	1	2o	CARDINAL
ijpds-4564	142	2	dcm nh ch r 85.0%	ORG
ijpds-4564	142	3	2	CARDINAL
ijpds-4564	142	4	3	CARDINAL
ijpds-4564	142	5	41	CARDINAL
ijpds-4564	143	1	alonso n & coworkers	ORG
ijpds-4564	143	2	r.	NORP
ijpds-4564	143	3	1s,3r)-3-(prop-2-yn-1-ylamino)-2,3	DATE
ijpds-4564	143	4	27	CARDINAL
ijpds-4564	143	5	1r,3r)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1hinden-1-ol 32	DATE
ijpds-4564	143	6	1s,3r)-3-[di(prop-2-yn-1-yl)amino]-2,3dihydro-1h-inden-1-ol	DATE
ijpds-4564	143	7	35	CARDINAL
ijpds-4564	143	8	1r,3r)-3-[di(prop-2-yn-1yl)amino]-2,3-dihydro-1h-inden-1-ol 38	DATE
ijpds-4564	143	9	28	CARDINAL
ijpds-4564	143	10	29	CARDINAL
ijpds-4564	143	11	eight	CARDINAL
ijpds-4564	143	12	r.	NORP
ijpds-4564	143	13	1r,3s)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1hinden-1-yl	DATE
ijpds-4564	143	14	30	DATE
ijpds-4564	143	15	1r,3s)-3-(prop-2-yn-1ylamino)-2,3	CARDINAL
ijpds-4564	143	16	31	DATE
ijpds-4564	143	17	1s,3s)-3-(prop-2-yn-1-ylamino)-2,3	DATE
ijpds-4564	143	18	33	DATE
ijpds-4564	143	19	1s,3s)-3-(prop-2-yn-1-ylamino)-2,3dihydro-1h-inden-1-yl	DATE
ijpds-4564	143	20	34	DATE
ijpds-4564	143	21	1s,3r)-3[di(prop-2-yn-1-yl)amino]-2,3-dihydro-1h	DATE
ijpds-4564	143	22	36	DATE
ijpds-4564	143	23	1s,3s)-3-(hepta-1,6-diyn-4	CARDINAL
ijpds-4564	143	24	37	DATE
ijpds-4564	143	25	1r,3r)-3[di(prop-2-yn-1-yl)amino]-2,3-dihydro-1h	DATE
ijpds-4564	143	26	39	DATE
ijpds-4564	143	27	1r,3r)-3-[di(prop-2-yn-1yl)amino]-2,3-dihydro-1h-inden-1-yl	DATE
ijpds-4564	143	28	40	DATE
ijpds-4564	145	1	three	CARDINAL
ijpds-4564	145	2	34	CARDINAL
ijpds-4564	145	3	36 & 39	DATE
ijpds-4564	145	4	44	CARDINAL
ijpds-4564	146	1	gonzález-díaz h &	ORG
ijpds-4564	147	1	3-hydroxy	QUANTITY
ijpds-4564	147	2	45	CARDINAL
ijpds-4564	148	1	1,3	CARDINAL
ijpds-4564	149	1	27	CARDINAL
ijpds-4564	149	2	32	DATE
ijpds-4564	149	3	35	DATE
ijpds-4564	149	4	38	DATE
ijpds-4564	149	5	1s,3r)-3-[di(prop-2-yn-1yl)amino]-2,3-dihydro-1h-inden-1-yl	QUANTITY
ijpds-4564	149	6	41	DATE
ijpds-4564	149	7	1r,3r)-3[di(prop-2-yn-1-yl)amino]-2,3-dihydro-1h	DATE
ijpds-4564	149	8	42	DATE
ijpds-4564	149	9	1s,3r)-3-[di(prop-2-yn-1-yl)amino]-2,3-dihydro-1hinden-1-yl	DATE
ijpds-4564	149	10	1r,3r)-3-[di(prop-2-yn-1yl)amino]-2,3-dihydro-1h-inden-1-yl benzoate 44	DATE
ijpds-4564	150	1	46	CARDINAL
ijpds-4564	152	1	ch3 ch3 nh	ORG
ijpds-4564	153	1	o	DATE
ijpds-4564	153	2	n ch3 ch3 nh	ORG
ijpds-4564	154	1	o	DATE
ijpds-4564	154	2	n ch3 ch3 nh ch	ORG
ijpds-4564	155	1	acn nh ch o o	PERSON
ijpds-4564	156	1	n ch3 ch3 nh	ORG
ijpds-4564	157	1	o	DATE
ijpds-4564	157	2	27 28	DATE
ijpds-4564	157	3	29	CARDINAL
ijpds-4564	157	4	34	CARDINAL
ijpds-4564	157	5	3a	CARDINAL
ijpds-4564	157	6	44	CARDINAL
ijpds-4564	158	1	rodríguez-borges j & coworkers	ORG
ijpds-4564	158	2	1	CARDINAL
ijpds-4564	159	1	6,7-dihydro-5h-cyclopenta[b]pyridine	QUANTITY
ijpds-4564	159	2	1oxide 45	DATE
ijpds-4564	159	3	6,7	CARDINAL
ijpds-4564	159	4	46	DATE
ijpds-4564	159	5	6,7	CARDINAL
ijpds-4564	159	6	48	DATE
ijpds-4564	159	7	5,6dihydro-7h-cyclopenta[b]pyridin-7-one	QUANTITY
ijpds-4564	159	8	50	CARDINAL
ijpds-4564	159	9	51	CARDINAL
ijpds-4564	160	1	47	CARDINAL
ijpds-4564	161	1	3	CARDINAL
ijpds-4564	161	2	2 | apr –	TIME
ijpds-4564	161	3	2024	CARDINAL
ijpds-4564	161	4	indian	NORP
ijpds-4564	161	5	j pharm drug	PRODUCT
ijpds-4564	162	1	50 n ch	QUANTITY
ijpds-4564	163	1	acn n ch	PERSON
ijpds-4564	164	1	o	DATE
ijpds-4564	164	2	ch3 ch3 ch	PERSON
ijpds-4564	165	1	o	DATE
ijpds-4564	165	2	ch3 ch3 ch n ch	PERSON
ijpds-4564	166	1	acn n ch	PERSON
ijpds-4564	167	1	o	DATE
ijpds-4564	167	2	ch3 ch3 ch nch	PERSON
ijpds-4564	168	1	ch3 ch3 ch	PERSON
ijpds-4564	168	2	35 36	DATE
ijpds-4564	168	3	3b	CARDINAL
ijpds-4564	168	4	44	CARDINAL
ijpds-4564	174	1	27 32	DATE
ijpds-4564	174	2	38	CARDINAL
ijpds-4564	174	3	41	CARDINAL
ijpds-4564	174	4	43 44	DATE
ijpds-4564	174	5	10	CARDINAL
ijpds-4564	174	6	44	CARDINAL
ijpds-4564	179	1	45	CARDINAL
ijpds-4564	179	2	51	CARDINAL
ijpds-4564	179	3	11	CARDINAL
ijpds-4564	179	4	47	CARDINAL
ijpds-4564	180	1	ma g & coworkers	ORG
ijpds-4564	180	2	seven	CARDINAL
ijpds-4564	180	3	dkr	ORG
ijpds-4564	180	4	candida antarctica	LOC
ijpds-4564	181	1	52	CARDINAL
ijpds-4564	181	2	2,3-dihydro-1h-inden-1-one	QUANTITY
ijpds-4564	183	1	hcl	PERSON
ijpds-4564	183	2	1e	CARDINAL
ijpds-4564	183	3	54	CARDINAL
ijpds-4564	184	1	1	CARDINAL
ijpds-4564	185	1	2	CARDINAL
ijpds-4564	185	2	n-[(1r)-2,3dihydro-1h-inden-1-yl]-2-methoxyacetamide 55 and	ORG
ijpds-4564	185	3	1	CARDINAL
ijpds-4564	186	1	r.	NORP
ijpds-4564	186	2	methanesulfonic	NORP
ijpds-4564	186	3	25.0%	PERCENT
ijpds-4564	187	1	48	CARDINAL
ijpds-4564	189	1	1	CARDINAL
ijpds-4564	189	2	colyer jt &	ORG
ijpds-4564	191	1	nabh4	DATE
ijpds-4564	192	1	53	CARDINAL
ijpds-4564	192	2	2	CARDINAL
ijpds-4564	192	3	56	CARDINAL
ijpds-4564	192	4	57	DATE
ijpds-4564	193	1	nabh4	ORG
ijpds-4564	193	2	58	DATE
ijpds-4564	194	1	57	CARDINAL
ijpds-4564	194	2	59	CARDINAL
ijpds-4564	195	1	58	DATE
ijpds-4564	195	2	59	CARDINAL
ijpds-4564	195	3	1	CARDINAL
ijpds-4564	195	4	1-s	QUANTITY
ijpds-4564	196	1	49	CARDINAL
ijpds-4564	197	1	1	CARDINAL
ijpds-4564	198	1	41	CARDINAL
ijpds-4564	198	2	50	CARDINAL
ijpds-4564	198	3	51	CARDINAL
ijpds-4564	199	1	49	CARDINAL
ijpds-4564	199	2	54	CARDINAL
ijpds-4564	199	3	chao	PERSON
ijpds-4564	200	1	58	CARDINAL
ijpds-4564	200	2	48	CARDINAL
ijpds-4564	200	3	59	CARDINAL
ijpds-4564	200	4	40	CARDINAL
ijpds-4564	201	1	fonseca t de s &	PERSON
ijpds-4564	202	1	53	CARDINAL
ijpds-4564	202	2	nabh4	ORG
ijpds-4564	202	3	2,3-dihydro-1h-inden-1-ol	QUANTITY
ijpds-4564	202	4	60	CARDINAL
ijpds-4564	203	1	23	CARDINAL
ijpds-4564	204	1	23	CARDINAL
ijpds-4564	204	2	1r)-1-azido-2,3-dihydro-1hindene 62	QUANTITY
ijpds-4564	204	3	1	CARDINAL
ijpds-4564	205	1	3	CARDINAL
ijpds-4564	205	2	2 | apr –	TIME
ijpds-4564	205	3	2024	CARDINAL
ijpds-4564	205	4	indian	NORP
ijpds-4564	205	5	j pharm drug	PRODUCT
ijpds-4564	205	6	51	CARDINAL
ijpds-4564	205	7	1	CARDINAL
ijpds-4564	205	8	methanesulfonic	NORP
ijpds-4564	206	1	63	CARDINAL
ijpds-4564	207	1	fernández r &	ORG
ijpds-4564	207	2	64	CARDINAL
ijpds-4564	207	3	lin fl &	ORG
ijpds-4564	208	1	65	CARDINAL
ijpds-4564	209	1	carvalho acl de m & coworkers	PERSON
ijpds-4564	209	2	2007-2015	DATE
ijpds-4564	209	3	66	CARDINAL
ijpds-4564	210	1	98.2%	PERCENT
ijpds-4564	212	1	hcl naoh	PERSON
ijpds-4564	212	2	2o 89.9%	PERCENT
ijpds-4564	213	1	93.5%	PERCENT
ijpds-4564	213	2	calb	GPE
ijpds-4564	213	3	pd	GPE
ijpds-4564	213	4	80.1%	PERCENT
ijpds-4564	214	1	76.2%	PERCENT
ijpds-4564	214	2	nh2 propargyl bromide	PERSON
ijpds-4564	214	3	59.7%	PERCENT
ijpds-4564	214	4	nh ch rm ipa methanesulfonic	ORG
ijpds-4564	214	5	83.1%	PERCENT
ijpds-4564	214	6	551	CARDINAL
ijpds-4564	214	7	3a	CARDINAL
ijpds-4564	214	8	52	DATE
ijpds-4564	214	9	48	CARDINAL
ijpds-4564	215	1	53	CARDINAL
ijpds-4564	215	2	nh2 ch3 ch3 ch3	PRODUCT
ijpds-4564	217	1	+ 56	DATE
ijpds-4564	217	2	4 n	CARDINAL
ijpds-4564	217	3	ch3 ch3 ch3 nabh4	PERSON
ijpds-4564	218	1	ch3 ch3 ch3 hcl 1-r	PERSON
ijpds-4564	218	2	57	CARDINAL
ijpds-4564	218	3	84.0%	PERCENT
ijpds-4564	218	4	ch3 ch3	ORG
ijpds-4564	218	5	59 90.0%	PERCENT
ijpds-4564	218	6	1-s	QUANTITY
ijpds-4564	218	7	3b	CARDINAL
ijpds-4564	218	8	1	CARDINAL
ijpds-4564	218	9	49	CARDINAL
ijpds-4564	221	1	86.0%	PERCENT
ijpds-4564	221	2	dbu	ORG
ijpds-4564	221	3	70.0%	PERCENT
ijpds-4564	221	4	pph3	ORG
ijpds-4564	221	5	koh thf	PERSON
ijpds-4564	221	6	2o	CARDINAL
ijpds-4564	221	7	70.0%	PERCENT
ijpds-4564	221	8	79.0%	PERCENT
ijpds-4564	221	9	98.0%	PERCENT
ijpds-4564	222	1	53 60	DATE
ijpds-4564	222	2	621	CARDINAL
ijpds-4564	222	3	4	CARDINAL
ijpds-4564	222	4	53	DATE
ijpds-4564	222	5	63	CARDINAL
ijpds-4564	223	1	sousa cad & coworkers	ORG
ijpds-4564	223	2	7r)-7-(prop2-yn-1-yloxy)-6,7	DATE
ijpds-4564	223	3	63	DATE
ijpds-4564	223	4	7s)-7-(prop-2-yn-1-yloxy)-6,7	DATE
ijpds-4564	223	5	64	CARDINAL
ijpds-4564	224	1	67	CARDINAL
ijpds-4564	225	1	47	CARDINAL
ijpds-4564	226	1	63 64	DATE
ijpds-4564	226	2	12	CARDINAL
ijpds-4564	226	3	67	CARDINAL
ijpds-4564	227	1	rizzo-aguiar	PERSON
ijpds-4564	227	2	r.	NORP
ijpds-4564	227	3	1	CARDINAL
ijpds-4564	227	4	c-7	ORG
ijpds-4564	227	5	48	DATE
ijpds-4564	227	6	67	CARDINAL
ijpds-4564	227	7	50	CARDINAL
ijpds-4564	227	8	69	DATE
ijpds-4564	227	9	70	CARDINAL
ijpds-4564	227	10	66	CARDINAL
ijpds-4564	227	11	68	CARDINAL
ijpds-4564	228	1	ch3 ch3 n	PERSON
ijpds-4564	228	2	ch3 ch3 n	PERSON
ijpds-4564	228	3	ch3 ch3 n	PERSON
ijpds-4564	228	4	n nh ch3 n nh ch3 ch3 n nh 65	ORG
ijpds-4564	228	5	66	CARDINAL
ijpds-4564	228	6	69 70	CARDINAL
ijpds-4564	228	7	13	CARDINAL
ijpds-4564	228	8	70	CARDINAL
ijpds-4564	229	1	aguilar n & coworkers	ORG
ijpds-4564	230	1	4	CARDINAL
ijpds-4564	231	1	1	CARDINAL
ijpds-4564	231	2	71	CARDINAL
ijpds-4564	232	1	3	CARDINAL
ijpds-4564	233	1	69	CARDINAL
ijpds-4564	234	1	nh2 + .hcl	PERSON
ijpds-4564	235	1	2o	CARDINAL
ijpds-4564	235	2	nh ch tartaric acid	LOC
ijpds-4564	235	3	45.0%	PERCENT
ijpds-4564	235	4	71	CARDINAL
ijpds-4564	235	5	5	CARDINAL
ijpds-4564	235	6	1	CARDINAL
ijpds-4564	235	7	69	CARDINAL
ijpds-4564	236	1	3	CARDINAL
ijpds-4564	236	2	2 | apr –	TIME
ijpds-4564	236	3	2024	CARDINAL
ijpds-4564	236	4	indian	NORP
ijpds-4564	236	5	j pharm drug	PRODUCT
ijpds-4564	236	6	52	CARDINAL
ijpds-4564	236	7	70	CARDINAL
ijpds-4564	236	8	sun y &	ORG
ijpds-4564	236	9	1r)-2,3dihydro-1h	CARDINAL
ijpds-4564	236	10	r.	NORP
ijpds-4564	236	11	1	CARDINAL
ijpds-4564	236	12	71	CARDINAL
ijpds-4564	237	1	71	CARDINAL
ijpds-4564	238	1	nh2	PERSON
ijpds-4564	238	2	ch3 ch +	PERSON
ijpds-4564	238	3	+ nh	GPE
ijpds-4564	240	1	1	CARDINAL
ijpds-4564	240	2	71	CARDINAL
ijpds-4564	240	3	6	CARDINAL
ijpds-4564	240	4	1	CARDINAL
ijpds-4564	240	5	71	CARDINAL
ijpds-4564	241	1	brenna d & coworkers	ORG
ijpds-4564	241	2	1	CARDINAL
ijpds-4564	241	3	53	CARDINAL
ijpds-4564	241	4	73r	DATE
ijpds-4564	242	1	72	CARDINAL
ijpds-4564	244	1	53	CARDINAL
ijpds-4564	244	2	nh	LOC
ijpds-4564	244	3	1	CARDINAL
ijpds-4564	244	4	72r 73r	DATE
ijpds-4564	244	5	7	CARDINAL
ijpds-4564	244	6	1	CARDINAL
ijpds-4564	244	7	53	CARDINAL
ijpds-4564	244	8	72	CARDINAL
ijpds-4564	245	1	matzel p & coworkers	ORG
ijpds-4564	245	2	3	CARDINAL
ijpds-4564	245	3	irs	ORG
ijpds-4564	246	1	73	CARDINAL
ijpds-4564	247	1	nh2 ch+ ir-14 58%	PERSON
ijpds-4564	247	2	nh2 ch+ ir-sip	PERSON
ijpds-4564	247	3	81%	PERCENT
ijpds-4564	247	4	3	CARDINAL
ijpds-4564	247	5	8	CARDINAL
ijpds-4564	247	6	53	CARDINAL
ijpds-4564	247	7	73	CARDINAL
ijpds-4564	248	1	raju nm & coworkers	ORG
ijpds-4564	248	2	r.	NORP
ijpds-4564	248	3	53	CARDINAL
ijpds-4564	248	4	1	CARDINAL
ijpds-4564	249	1	3bromoprop-1-ene	DATE
ijpds-4564	249	2	1	CARDINAL
ijpds-4564	249	3	74	CARDINAL
ijpds-4564	250	1	53	CARDINAL
ijpds-4564	250	2	3	CARDINAL
ijpds-4564	251	1	3(prop-2-yn-1-ylamino)-2,3	DATE
ijpds-4564	252	1	74	CARDINAL
ijpds-4564	253	1	3	CARDINAL
ijpds-4564	254	1	two	CARDINAL
ijpds-4564	254	2	77	CARDINAL
ijpds-4564	254	3	n-[(2e	LAW
ijpds-4564	254	4	78	CARDINAL
ijpds-4564	255	1	74	CARDINAL
ijpds-4564	257	1	53 o	DATE
ijpds-4564	257	2	53	CARDINAL
ijpds-4564	257	3	ch2	ORG
ijpds-4564	257	4	ch2	PRODUCT
ijpds-4564	257	5	ch nh2	PERSON
ijpds-4564	258	1	hbr nh ch o 1 74	ORG
ijpds-4564	258	2	9a	CARDINAL
ijpds-4564	258	3	74	CARDINAL
ijpds-4564	259	1	nh ch rs lindlar catalyst	PERSON
ijpds-4564	259	2	3oh 74	DATE
ijpds-4564	259	3	3	CARDINAL
ijpds-4564	259	4	lindlar catalyst	LOC
ijpds-4564	259	5	ch2	PRODUCT
ijpds-4564	259	6	+ nh	GPE
ijpds-4564	259	7	77 78	CARDINAL
ijpds-4564	259	8	9b	CARDINAL
ijpds-4564	259	9	74	CARDINAL
ijpds-4564	260	1	sun h &	ORG
ijpds-4564	260	2	75	CARDINAL
ijpds-4564	261	1	63	CARDINAL
ijpds-4564	262	1	3	CARDINAL
ijpds-4564	263	1	2 | apr –	TIME
ijpds-4564	263	2	2024	CARDINAL
ijpds-4564	263	3	indian	NORP
ijpds-4564	263	4	j pharm drug	PRODUCT
ijpds-4564	263	5	53	CARDINAL
ijpds-4564	263	6	76	CARDINAL
ijpds-4564	264	1	66	CARDINAL
ijpds-4564	264	2	67	DATE
ijpds-4564	264	3	73	CARDINAL
ijpds-4564	264	4	bio-catalysm	ORG
ijpds-4564	265	1	galvão ws & coworkers	ORG
ijpds-4564	265	2	60	CARDINAL
ijpds-4564	265	3	77	CARDINAL
ijpds-4564	267	1	60 23 61	CARDINAL
ijpds-4564	267	2	10	CARDINAL
ijpds-4564	267	3	23	CARDINAL
ijpds-4564	267	4	61	DATE
ijpds-4564	267	5	60	CARDINAL
ijpds-4564	267	6	77	CARDINAL
ijpds-4564	268	1	xiao x & coworkers	ORG
ijpds-4564	268	2	-sch2-	ORG
ijpds-4564	268	3	och2ch2-	DATE
ijpds-4564	269	1	79	CARDINAL
ijpds-4564	270	1	o ch nh o	PERSON
ijpds-4564	270	2	79	CARDINAL
ijpds-4564	270	3	14	CARDINAL
ijpds-4564	270	4	79	CARDINAL
ijpds-4564	271	1	pérez-venegas m & coworkers	ORG
ijpds-4564	271	2	candida antarctica	LOC
ijpds-4564	273	1	1 to 3	CARDINAL
ijpds-4564	273	2	80	DATE
ijpds-4564	274	1	aqueous hcl	PERSON
ijpds-4564	274	2	80	CARDINAL
ijpds-4564	274	3	79	CARDINAL
ijpds-4564	275	1	avila-ortiz cg & coworkers	ORG
ijpds-4564	276	1	80	CARDINAL
ijpds-4564	276	2	79	CARDINAL
ijpds-4564	277	1	elshorbagi	ORG
ijpds-4564	277	2	81	CARDINAL
ijpds-4564	278	1	81	CARDINAL
ijpds-4564	279	1	82	CARDINAL
ijpds-4564	280	1	nh2 candida antarctica	PERSON
ijpds-4564	280	2	dioxane ch o s	PERSON
ijpds-4564	281	1	o	DATE
ijpds-4564	281	2	nh ch3	ORG
ijpds-4564	282	1	1 380	CARDINAL
ijpds-4564	282	2	hcl	PERSON
ijpds-4564	282	3	1	CARDINAL
ijpds-4564	282	4	11	CARDINAL
ijpds-4564	282	5	1	CARDINAL
ijpds-4564	282	6	79	CARDINAL
ijpds-4564	283	1	15	CARDINAL
ijpds-4564	283	2	81	CARDINAL
ijpds-4564	283	3	82	CARDINAL
ijpds-4564	284	1	li j & coworkers	ORG
ijpds-4564	284	2	aminoindan groups	PERSON
ijpds-4564	284	3	1	CARDINAL
ijpds-4564	284	4	1	CARDINAL
ijpds-4564	284	5	3	CARDINAL
ijpds-4564	284	6	83	CARDINAL
ijpds-4564	285	1	ramachandran pv & coworkers	ORG
ijpds-4564	285	2	53	CARDINAL
ijpds-4564	285	3	84	CARDINAL
ijpds-4564	287	1	92%	PERCENT
ijpds-4564	287	2	53	CARDINAL
ijpds-4564	287	3	12	CARDINAL
ijpds-4564	287	4	53	CARDINAL
ijpds-4564	287	5	84	CARDINAL
ijpds-4564	288	1	ying p & coworkers	ORG
ijpds-4564	289	1	3	CARDINAL
ijpds-4564	289	2	1	CARDINAL
ijpds-4564	289	3	85	CARDINAL
ijpds-4564	290	1	zhang k & coworkers	ORG
ijpds-4564	291	1	53	CARDINAL
ijpds-4564	291	2	86	CARDINAL
ijpds-4564	292	1	dugarte-dugarte aj &	PERSON
ijpds-4564	293	1	3	CARDINAL
ijpds-4564	294	1	2 | apr –	TIME
ijpds-4564	294	2	2024	CARDINAL
ijpds-4564	294	3	indian	NORP
ijpds-4564	294	4	j pharm drug	PRODUCT
ijpds-4564	294	5	54	DATE
ijpds-4564	294	6	dft	ORG
ijpds-4564	294	7	87	CARDINAL
ijpds-4564	295	1	twelve	CARDINAL
ijpds-4564	295	2	1 to 12	CARDINAL
ijpds-4564	296	1	eighty one	CARDINAL
ijpds-4564	296	2	1 to 15	CARDINAL
ijpds-4564	296	3	r.	NORP
ijpds-4564	297	1	11	CARDINAL
ijpds-4564	303	1	1	CARDINAL
ijpds-4564	304	1	lerner	PERSON
ijpds-4564	305	1	vienna	GPE
ijpds-4564	305	2	springer vienna	GPE
ijpds-4564	305	3	1998	DATE
ijpds-4564	305	4	301–5	CARDINAL
ijpds-4564	306	1	2	CARDINAL
ijpds-4564	306	2	chen jj	PERSON
ijpds-4564	308	1	2008	DATE
ijpds-4564	309	1	21(4):244–53	CARDINAL
ijpds-4564	310	1	3	CARDINAL
ijpds-4564	311	1	rasagiline mesylate	ORG
ijpds-4564	314	1	4	CARDINAL
ijpds-4564	315	1	lecht s	PERSON
ijpds-4564	315	2	haroutiunian s	ORG
ijpds-4564	317	1	clin	PERSON
ijpds-4564	317	2	manag.	GPE
ijpds-4564	318	1	2007	DATE
ijpds-4564	319	1	3(3):467–74	CARDINAL
ijpds-4564	320	1	5	CARDINAL
ijpds-4564	321	1	chen jj	PERSON
ijpds-4564	321	2	wilkinson jr.	PERSON
ijpds-4564	323	1	j clin pharmacol	PERSON
ijpds-4564	323	2	2012	DATE
ijpds-4564	324	1	52(5):620–8	DATE
ijpds-4564	325	1	6	CARDINAL
ijpds-4564	325	2	finberg jpm	PERSON
ijpds-4564	325	3	jm	ORG
ijpds-4564	327	1	2016	CARDINAL
ijpds-4564	327	2	7	CARDINAL
ijpds-4564	327	3	7	CARDINAL
ijpds-4564	327	4	rasagiline	NORP
ijpds-4564	329	1	8	CARDINAL
ijpds-4564	331	1	1981	DATE
ijpds-4564	331	2	10	CARDINAL
ijpds-4564	332	1	finberg jp	PERSON
ijpds-4564	333	1	1981	DATE
ijpds-4564	333	2	11	CARDINAL
ijpds-4564	334	1	saralaya ss	PERSON
ijpds-4564	336	1	indian	NORP
ijpds-4564	337	1	2023	CARDINAL
ijpds-4564	337	2	2(4):132–47	CARDINAL
ijpds-4564	338	1	12	CARDINAL
ijpds-4564	338	2	youdim mbh	PERSON
ijpds-4564	338	3	finberg jpm	PERSON
ijpds-4564	339	1	npropargyl-aminoindan	GPE
ijpds-4564	341	1	5457133	DATE
ijpds-4564	342	1	13	CARDINAL
ijpds-4564	344	1	us	GPE
ijpds-4564	345	1	1996	DATE
ijpds-4564	345	2	5486541	DATE
ijpds-4564	346	1	14	CARDINAL
ijpds-4564	347	1	lawson wb	PERSON
ijpds-4564	347	2	rao gjs	PERSON
ijpds-4564	348	1	alpha.-chymotrypsin	PERSON
ijpds-4564	350	1	1980	DATE
ijpds-4564	350	2	19(10):2133–9	CARDINAL
ijpds-4564	351	1	15	CARDINAL
ijpds-4564	351	2	jacques j	PERSON
ijpds-4564	352	1	nashville	GPE
ijpds-4564	352	2	tn	ORG
ijpds-4564	352	3	john wiley & sons	ORG
ijpds-4564	353	1	1981	DATE
ijpds-4564	354	1	16	CARDINAL
ijpds-4564	354	2	maruyama w	PERSON
ijpds-4564	354	3	akao y	PERSON
ijpds-4564	354	4	s)-aminoindan	ORDINAL
ijpds-4564	354	5	tv1022	GPE
ijpds-4564	356	1	vienna	GPE
ijpds-4564	356	2	vienna	GPE
ijpds-4564	357	1	2000	DATE
ijpds-4564	357	2	171–86	CARDINAL
ijpds-4564	358	1	17	CARDINAL
ijpds-4564	358	2	maruyama w	PERSON
ijpds-4564	358	3	youdim mbh	PERSON
ijpds-4564	358	4	naoi m.	PERSON
ijpds-4564	358	5	n‐propargylamine‐1 (r)‐ aminoindan	ORG
ijpds-4564	358	6	tv1022	GPE
ijpds-4564	359	1	ann n y acad sci.	PERSON
ijpds-4564	359	2	2001	DATE
ijpds-4564	359	3	939(1):320–9	CARDINAL
ijpds-4564	360	1	18	CARDINAL
ijpds-4564	360	2	youdim mbh	PERSON
ijpds-4564	361	1	mao-b. br j pharmacol.	ORG
ijpds-4564	362	1	2001	DATE
ijpds-4564	363	1	132(2):500–6. 19	DATE
ijpds-4564	363	2	youdim mbh	PERSON
ijpds-4564	363	3	weinstock m.	PERSON
ijpds-4564	366	1	2001	DATE
ijpds-4564	366	2	21(6):555–73	CARDINAL
ijpds-4564	367	1	20	CARDINAL
ijpds-4564	367	2	akao y	PERSON
ijpds-4564	367	3	maruyama w	GPE
ijpds-4564	367	4	shimizu s	PERSON
ijpds-4564	368	1	n‐methyl	CARDINAL
ijpds-4564	368	2	bcl‐2	ORG
ijpds-4564	368	3	n‐propargyl‐1	GPE
ijpds-4564	369	1	j neurochem.	PERSON
ijpds-4564	370	1	2002	DATE
ijpds-4564	372	1	21	CARDINAL
ijpds-4564	372	2	maruyama w	PERSON
ijpds-4564	372	3	boulton aa	PERSON
ijpds-4564	372	4	davis ba	PERSON
ijpds-4564	372	5	n methyl(r	GPE
ijpds-4564	373	1	vienna	GPE
ijpds-4564	374	1	2001	DATE
ijpds-4564	375	1	108(1):11–24	CARDINAL
ijpds-4564	376	1	22	CARDINAL
ijpds-4564	376	2	yu ph	PERSON
ijpds-4564	376	3	davis ba	PERSON
ijpds-4564	376	4	boulton aa	PERSON
ijpds-4564	379	1	boston	GPE
ijpds-4564	379	2	1995	DATE
ijpds-4564	379	3	17–23	CARDINAL
ijpds-4564	379	4	23	CARDINAL
ijpds-4564	380	1	berry md	PERSON
ijpds-4564	380	2	boulton aa	PERSON
ijpds-4564	382	1	neurotoxicol	TIME
ijpds-4564	383	1	2002	DATE
ijpds-4564	383	2	24(5):667–73	CARDINAL
ijpds-4564	384	1	24	CARDINAL
ijpds-4564	385	1	herzig y	PERSON
ijpds-4564	385	2	goren t	PERSON
ijpds-4564	385	3	aminoindan	GPE
ijpds-4564	385	4	https://pubchem.ncbi.nlm.nih.gov/compound/rasagiline	NORP
ijpds-4564	385	5	3	CARDINAL
ijpds-4564	386	1	2 | apr –	TIME
ijpds-4564	386	2	2024	CARDINAL
ijpds-4564	386	3	indian	NORP
ijpds-4564	386	4	j pharm drug	PRODUCT
ijpds-4564	386	5	55	CARDINAL
ijpds-4564	388	1	2002	DATE
ijpds-4564	388	2	45(24):5260–79	CARDINAL
ijpds-4564	389	1	25	CARDINAL
ijpds-4564	389	2	maruyama w	PERSON
ijpds-4564	389	3	weinstock m	PERSON
ijpds-4564	391	1	neurosci lett.	PERSON
ijpds-4564	391	2	2003	DATE
ijpds-4564	392	1	341(3):233–6	CARDINAL
ijpds-4564	392	2	26	CARDINAL
ijpds-4564	392	3	amit t	PERSON
ijpds-4564	394	1	j. 2002	GPE
ijpds-4564	394	2	16(12):1674–6	CARDINAL
ijpds-4564	395	1	27	CARDINAL
ijpds-4564	396	1	hébert g	PERSON
ijpds-4564	398	1	2003	DATE
ijpds-4564	399	1	18(2):147–53	CARDINAL
ijpds-4564	400	1	28	CARDINAL
ijpds-4564	401	1	binda	PERSON
ijpds-4564	401	2	li m	PERSON
ijpds-4564	402	1	four	CARDINAL
ijpds-4564	404	1	2004	DATE
ijpds-4564	404	2	47(7):1767–74	DATE
ijpds-4564	405	1	29	CARDINAL
ijpds-4564	405	2	hubálek f	PERSON
ijpds-4564	405	3	li m	PERSON
ijpds-4564	408	1	2004	DATE
ijpds-4564	408	2	47(7):1760–6	DATE
ijpds-4564	408	3	30	CARDINAL
ijpds-4564	409	1	reuter	PERSON
ijpds-4564	410	1	j neurol	PERSON
ijpds-4564	411	1	2004	DATE
ijpds-4564	411	2	251(9	CARDINAL
ijpds-4564	412	1	31	CARDINAL
ijpds-4564	412	2	amit t	PERSON
ijpds-4564	412	3	the anti‐parkinson drug	ORG
ijpds-4564	414	1	2004	DATE
ijpds-4564	414	2	89(5):1119–25	CARDINAL
ijpds-4564	415	1	32	CARDINAL
ijpds-4564	417	1	neurol	GPE
ijpds-4564	418	1	2004	DATE
ijpds-4564	419	1	61(4):561	CARDINAL
ijpds-4564	420	1	33	CARDINAL
ijpds-4564	422	1	neurol	GPE
ijpds-4564	423	1	2005	DATE
ijpds-4564	424	1	62(2):241	CARDINAL
ijpds-4564	425	1	34	CARDINAL
ijpds-4564	426	1	brooks dj	PERSON
ijpds-4564	426	2	melamed e	PERSON
ijpds-4564	427	1	lancet	ORG
ijpds-4564	428	1	2005	DATE
ijpds-4564	428	2	365(9463):947–54	DATE
ijpds-4564	428	3	35	CARDINAL
ijpds-4564	429	1	youdim mbh	PERSON
ijpds-4564	429	2	maruyama w	PERSON
ijpds-4564	429	3	naoi m. neuropharmacological	PERSON
ijpds-4564	429	4	antiparkinsonian	NORP
ijpds-4564	430	1	today	DATE
ijpds-4564	430	2	barc	FAC
ijpds-4564	431	1	2005	DATE
ijpds-4564	432	1	41(6):369	CARDINAL
ijpds-4564	433	1	36	CARDINAL
ijpds-4564	434	1	binda	PERSON
ijpds-4564	434	2	li m	PERSON
ijpds-4564	437	1	2005	DATE
ijpds-4564	437	2	48(26):8148–54	CARDINAL
ijpds-4564	438	1	37	CARDINAL
ijpds-4564	438	2	youdim mbh	PERSON
ijpds-4564	438	3	tipton kf	PERSON
ijpds-4564	440	1	nat rev neurosci	PERSON
ijpds-4564	441	1	2006	DATE
ijpds-4564	442	1	7(4):295–309	CARDINAL
ijpds-4564	444	1	oldfield v	PERSON
ijpds-4564	444	2	keating gm	PERSON
ijpds-4564	444	3	perry cm.	PERSON
ijpds-4564	446	1	2007	DATE
ijpds-4564	446	2	67(11):1657–79	CARDINAL
ijpds-4564	447	1	39	CARDINAL
ijpds-4564	448	1	gallagher da	PERSON
ijpds-4564	448	2	schrag a.	PERSON
ijpds-4564	449	1	2008	DATE
ijpds-4564	449	2	22(7):563–86	CARDINAL
ijpds-4564	450	1	40	CARDINAL
ijpds-4564	451	1	tatendra rk	PERSON
ijpds-4564	451	2	suneel kk	PERSON
ijpds-4564	453	1	derpharmachemica	PERSON
ijpds-4564	454	1	2011	DATE
ijpds-4564	455	1	41	CARDINAL
ijpds-4564	456	1	kapubalu sk	PERSON
ijpds-4564	456	2	kovvuri	PERSON
ijpds-4564	456	3	gunnam jmr	PERSON
ijpds-4564	458	1	42	CARDINAL
ijpds-4564	459	1	gittos mw	PERSON
ijpds-4564	459	2	james jw	PERSON
ijpds-4564	459	3	wiggins lf	PERSON
ijpds-4564	460	1	1aminoindane	CARDINAL
ijpds-4564	462	1	1966	DATE
ijpds-4564	462	2	1037014a	DATE
ijpds-4564	463	1	43	CARDINAL
ijpds-4564	464	1	gittos mw	PERSON
ijpds-4564	464	2	james jw	PERSON
ijpds-4564	464	3	wiggins lf	PERSON
ijpds-4564	466	1	1970	DATE
ijpds-4564	466	2	3513244	DATE
ijpds-4564	467	1	44	DATE
ijpds-4564	467	2	alonso n	PERSON
ijpds-4564	467	3	caamaño o	PERSON
ijpds-4564	467	4	romero-duran	PERSON
ijpds-4564	467	5	fj	NORP
ijpds-4564	468	1	acs chem neurosci	ORG
ijpds-4564	469	1	2013	DATE
ijpds-4564	469	2	4(10):1393-403	DATE
ijpds-4564	470	1	45	CARDINAL
ijpds-4564	471	1	gonzález-díaz h	ORG
ijpds-4564	471	2	prado-prado	PERSON
ijpds-4564	472	1	j proteome res	PERSON
ijpds-4564	472	2	2011	DATE
ijpds-4564	472	3	46	DATE
ijpds-4564	473	1	luan f	PERSON
ijpds-4564	473	2	cordeiro mnds	PERSON
ijpds-4564	473	3	1,3	CARDINAL
ijpds-4564	474	1	bioorg med chem	ORG
ijpds-4564	475	1	2013	DATE
ijpds-4564	475	2	21(7):1870–9	CARDINAL
ijpds-4564	476	1	47	CARDINAL
ijpds-4564	477	1	rodríguez-borges j	PERSON
ijpds-4564	477	2	pereira c	PERSON
ijpds-4564	477	3	salgado s	PERSON
ijpds-4564	477	4	1	CARDINAL
ijpds-4564	479	1	2013	DATE
ijpds-4564	479	2	24(07):837–8	CARDINAL
ijpds-4564	479	3	48	DATE
ijpds-4564	480	1	ma g	PERSON
ijpds-4564	481	1	zhang p	PERSON
ijpds-4564	483	1	2014	DATE
ijpds-4564	483	2	18(10):1169-74	CARDINAL
ijpds-4564	484	1	49	DATE
ijpds-4564	485	1	colyer jt	PERSON
ijpds-4564	485	2	andersen ng	PERSON
ijpds-4564	486	1	diastereofacial	ORG
ijpds-4564	488	1	2006	DATE
ijpds-4564	488	2	71(18):6859–62	CARDINAL
ijpds-4564	489	1	50	CARDINAL
ijpds-4564	490	1	lidor	PERSON
ijpds-4564	490	2	bahar e	PERSON
ijpds-4564	491	1	1	CARDINAL
ijpds-4564	493	1	1997	DATE
ijpds-4564	493	2	29(6):701–6	CARDINAL
ijpds-4564	494	1	51	CARDINAL
ijpds-4564	495	1	brunner h	ORG
ijpds-4564	495	2	becker r	PERSON
ijpds-4564	495	3	gauder s. asymmetric catalysis	PERSON
ijpds-4564	496	1	29	CARDINAL
ijpds-4564	498	1	1986	DATE
ijpds-4564	498	2	5(4):739	CARDINAL
ijpds-4564	498	3	46	DATE
ijpds-4564	498	4	52	CARDINAL
ijpds-4564	499	1	takei	PERSON
ijpds-4564	499	2	asymmetric hydrosilylation	PERSON
ijpds-4564	500	1	camb	PERSON
ijpds-4564	501	1	2001	DATE
ijpds-4564	501	2	22):2360–1	CARDINAL
ijpds-4564	502	1	reddy rp	PERSON
ijpds-4564	502	2	davies hml	PERSON
ijpds-4564	503	1	dirhodium	PERSON
ijpds-4564	504	1	org lett	FAC
ijpds-4564	505	1	2006	DATE
ijpds-4564	505	2	8(22):5013–6	CARDINAL
ijpds-4564	506	1	54	CARDINAL
ijpds-4564	507	1	gutman al	PERSON
ijpds-4564	508	1	tetrahedron asymmetry	ORG
ijpds-4564	509	1	1998	DATE
ijpds-4564	510	1	55	DATE
ijpds-4564	511	1	juaristi e	PERSON
ijpds-4564	511	2	león-	GPE
ijpds-4564	511	3	reyes	ORG
ijpds-4564	513	1	3	CARDINAL
ijpds-4564	514	1	4	CARDINAL
ijpds-4564	515	1	tetrahedron asymmetry	ORG
ijpds-4564	516	1	1999	DATE
ijpds-4564	516	2	10(13):2441–95	CARDINAL
ijpds-4564	517	1	56	CARDINAL
ijpds-4564	517	2	uiterweerd	GPE
ijpds-4564	517	3	pgh	GPE
ijpds-4564	517	4	van der sluis m	PERSON
ijpds-4564	517	5	kaptein	PERSON
ijpds-4564	519	1	tetrahedron asymmetry	ORG
ijpds-4564	520	1	2003	DATE
ijpds-4564	520	2	14(22):3479–85	DATE
ijpds-4564	521	1	https://www.derpharmachemica.com/%20pharma-chemica/a-new-process-for-the-synthesis-of-enantiome%20rically-pure-rnpropargyl1aminoindan-mesylaterasagiline-mesylate.pdf https://www.derpharmachemica.com/%20pharma-chemica/a-new-process-for-the-synthesis-of-enantiome%20rically-pure-rnpropargyl1aminoindan-mesylaterasagiline-mesylate.pdf https://www.derpharmachemica.com/%20pharma-chemica/a-new-process-for-the-synthesis-of-enantiome%20rically-pure-rnpropargyl1aminoindan-mesylaterasagiline-mesylate.pdf https://www.derpharmachemica.com/%20pharma-chemica/a-new-process-for-the-synthesis-of-enantiome%20rically-pure-rnpropargyl1aminoindan-mesylaterasagiline-mesylate.pdf https://www.globalresearchonline.net/journalcontents/v12-1/029.pdf https://www.globalresearchonline.net/journalcontents/v12-1/029.pdf	ORG
ijpds-4564	521	2	3	CARDINAL
ijpds-4564	521	3	2 | apr –	TIME
ijpds-4564	521	4	2024	CARDINAL
ijpds-4564	521	5	indian	NORP
ijpds-4564	521	6	j pharm drug	PRODUCT
ijpds-4564	521	7	56 57	DATE
ijpds-4564	522	1	pakulski mm	PERSON
ijpds-4564	522	2	bosiak mj	PERSON
ijpds-4564	524	1	tetrahedron asymmetry	ORG
ijpds-4564	525	1	2012	DATE
ijpds-4564	526	1	23(9):716–21	CARDINAL
ijpds-4564	527	1	58	CARDINAL
ijpds-4564	528	1	leisch h	ORG
ijpds-4564	528	2	cyclohexylamine oxidase	PERSON
ijpds-4564	530	1	2012	DATE
ijpds-4564	531	1	gutman al	PERSON
ijpds-4564	531	2	meyer e	PERSON
ijpds-4564	531	3	kalerin e	GPE
ijpds-4564	533	1	biotechnol bioeng	PERSON
ijpds-4564	533	2	1992	DATE
ijpds-4564	533	3	40(7):760–7	CARDINAL
ijpds-4564	534	1	60	CARDINAL
ijpds-4564	535	1	gutman al	PERSON
ijpds-4564	535	2	meyer e	PERSON
ijpds-4564	536	1	ann n y acad sci.	PERSON
ijpds-4564	536	2	1996	DATE
ijpds-4564	537	1	799(1):620–32	CARDINAL
ijpds-4564	537	2	61	CARDINAL
ijpds-4564	538	1	malik ms	PERSON
ijpds-4564	538	2	park e-s	PERSON
ijpds-4564	538	3	j-s. ω-transaminase-catalyzed	ORG
ijpds-4564	540	1	2012	DATE
ijpds-4564	541	1	14(8):2137	CARDINAL
ijpds-4564	542	1	62	CARDINAL
ijpds-4564	543	1	päiviö m	PERSON
ijpds-4564	543	2	kanerva	ORG
ijpds-4564	543	3	candida antarctica	LOC
ijpds-4564	544	1	tetrahedron asymmetry	ORG
ijpds-4564	545	1	2012	DATE
ijpds-4564	545	2	23(3	CARDINAL
ijpds-4564	547	1	fonseca t de s	PERSON
ijpds-4564	547	2	silva mr da	PERSON
ijpds-4564	547	3	de oliveira	PERSON
ijpds-4564	549	1	catal	ORG
ijpds-4564	549	2	2015	CARDINAL
ijpds-4564	550	1	492:76–82	CARDINAL
ijpds-4564	551	1	fernández	PERSON
ijpds-4564	551	2	trans-cycloalkyl	ORG
ijpds-4564	553	1	2007	DATE
ijpds-4564	553	2	63(29):6755–63	CARDINAL
ijpds-4564	555	1	lin fl	PERSON
ijpds-4564	555	2	hoyt	PERSON
ijpds-4564	555	3	van halbeek h	ORG
ijpds-4564	558	1	2005	DATE
ijpds-4564	559	1	127(8):2686–95	CARDINAL
ijpds-4564	560	1	66	CARDINAL
ijpds-4564	561	1	carvalho acl de m	PERSON
ijpds-4564	561	2	fonseca t de s	PERSON
ijpds-4564	561	3	de mattos mc	PERSON
ijpds-4564	563	1	j mol sci	PERSON
ijpds-4564	563	2	2015	DATE
ijpds-4564	563	3	16(12):29682–716	CARDINAL
ijpds-4564	563	4	67	CARDINAL
ijpds-4564	564	1	sampaio-dias	PERSON
ijpds-4564	564	2	rizzo-aguiar	PERSON
ijpds-4564	564	3	7-(1	CARDINAL
ijpds-4564	564	4	1pyrindan-7	CARDINAL
ijpds-4564	565	1	rsc adv	PERSON
ijpds-4564	565	2	2015	CARDINAL
ijpds-4564	565	3	5(126):104509–15	CARDINAL
ijpds-4564	566	1	68	CARDINAL
ijpds-4564	567	1	rizzo-aguiar	PERSON
ijpds-4564	567	2	sousa	PERSON
ijpds-4564	567	3	garcia-mera	PERSON
ijpds-4564	567	4	1	CARDINAL
ijpds-4564	569	1	2016	CARDINAL
ijpds-4564	569	2	5(6):21–7	CARDINAL
ijpds-4564	571	1	aguilar n	PERSON
ijpds-4564	571	2	garcia b	PERSON
ijpds-4564	571	3	cunningham m	ORG
ijpds-4564	571	4	three week	DATE
ijpds-4564	573	1	2016	CARDINAL
ijpds-4564	573	2	93(5):937–40	CARDINAL
ijpds-4564	574	1	70	CARDINAL
ijpds-4564	575	1	sun y	PERSON
ijpds-4564	575	2	yan y	PERSON
ijpds-4564	575	3	feng x	PERSON
ijpds-4564	577	1	2014	DATE
ijpds-4564	578	1	https://patents.google.com/patent/ cn103804200a	PERSON
ijpds-4564	578	2	71	CARDINAL
ijpds-4564	579	1	sun y	PERSON
ijpds-4564	579	2	zhang x	PERSON
ijpds-4564	579	3	two	CARDINAL
ijpds-4564	580	1	rsc adv.	PERSON
ijpds-4564	580	2	2016	DATE
ijpds-4564	581	1	6(108):106268–74	DATE
ijpds-4564	582	1	72	DATE
ijpds-4564	583	1	brenna	PERSON
ijpds-4564	585	1	bioorg med chem	ORG
ijpds-4564	586	1	2017	CARDINAL
ijpds-4564	587	1	25(23):6242–7	CARDINAL
ijpds-4564	588	1	73	CARDINAL
ijpds-4564	589	1	matzel p	PERSON
ijpds-4564	589	2	gand	PERSON
ijpds-4564	589	3	höhne m.	PERSON
ijpds-4564	589	4	one	CARDINAL
ijpds-4564	591	1	2017	CARDINAL
ijpds-4564	591	2	19(2):385–9	DATE
ijpds-4564	592	1	74	CARDINAL
ijpds-4564	593	1	babu jm	PERSON
ijpds-4564	593	2	rao bv	PERSON
ijpds-4564	594	1	asian	NORP
ijpds-4564	595	1	2017	CARDINAL
ijpds-4564	596	1	29(6):1357–9	CARDINAL
ijpds-4564	597	1	75	CARDINAL
ijpds-4564	598	1	sun h	ORG
ijpds-4564	598	2	zhang h	GPE
ijpds-4564	598	3	ang el	GPE
ijpds-4564	598	4	biocatalysis	PERSON
ijpds-4564	599	1	bioorg med chem	ORG
ijpds-4564	600	1	2018	DATE
ijpds-4564	600	2	26(7):1275-84	CARDINAL
ijpds-4564	601	1	76	DATE
ijpds-4564	602	1	gonzález-martínez	PERSON
ijpds-4564	602	2	stereoselective biocatalysis	PERSON
ijpds-4564	604	1	2018	DATE
ijpds-4564	605	1	36(2):102–30	CARDINAL
ijpds-4564	606	1	77	CARDINAL
ijpds-4564	606	2	galvão ws	PERSON
ijpds-4564	606	3	pinheiro bb	PERSON
ijpds-4564	606	4	golçalves lrb	ORG
ijpds-4564	606	5	biocatalyst	PERSON
ijpds-4564	607	1	sci	PERSON
ijpds-4564	607	2	2018	DATE
ijpds-4564	608	1	53(20):14121–37	CARDINAL
ijpds-4564	610	1	xiao x	PERSON
ijpds-4564	610	2	zhang x-x	PERSON
ijpds-4564	610	3	2,3-dihydro-1h-inden-1	QUANTITY
ijpds-4564	612	1	2018	DATE
ijpds-4564	613	1	145:588	CARDINAL
ijpds-4564	613	2	93	CARDINAL
ijpds-4564	614	1	79	CARDINAL
ijpds-4564	615	1	pérez-venegas m	ORG
ijpds-4564	615	2	e. mechanoenzymatic resolution	ORG
ijpds-4564	616	1	tetrahedron	ORG
ijpds-4564	617	1	2018	DATE
ijpds-4564	618	1	74(44):6453–8	CARDINAL
ijpds-4564	620	1	avila-ortiz cg	ORG
ijpds-4564	620	2	pérez-venegas m	ORG
ijpds-4564	620	3	vargas-caporali j	PERSON
ijpds-4564	622	1	tetrahedron lett.	PERSON
ijpds-4564	623	1	2019	DATE
ijpds-4564	624	1	60(27):1749–57	CARDINAL
ijpds-4564	626	1	chaudhary s	PERSON
ijpds-4564	626	2	alshemali ka	PERSON
ijpds-4564	628	1	sci	ORG
ijpds-4564	628	2	2020	DATE
ijpds-4564	631	1	first	ORDINAL
ijpds-4564	633	1	2020	DATE
ijpds-4564	634	1	li j	PERSON
ijpds-4564	634	2	han	NORP
ijpds-4564	634	3	chen c-f.	PERSON
ijpds-4564	634	4	1	CARDINAL
ijpds-4564	634	5	3	CARDINAL
ijpds-4564	635	1	2021	CARDINAL
ijpds-4564	635	2	26(3):536	CARDINAL
ijpds-4564	636	1	84	CARDINAL
ijpds-4564	637	1	ramachandran	PERSON
ijpds-4564	637	2	choudhary s	PERSON
ijpds-4564	637	3	singh a. trimethyl boratecatalyzed	PERSON
ijpds-4564	639	1	2021	CARDINAL
ijpds-4564	639	2	86(5):4274–80	CARDINAL
ijpds-4564	640	1	ying p	PERSON
ijpds-4564	640	2	yu j	PERSON
ijpds-4564	640	3	su w.	PERSON
ijpds-4564	641	1	adv synth catal	ORG
ijpds-4564	641	2	2021	CARDINAL
ijpds-4564	643	1	zhang k	PERSON
ijpds-4564	643	2	zhu j	PERSON
ijpds-4564	644	1	bioeng biotechnol	GPE
ijpds-4564	645	1	2021	CARDINAL
ijpds-4564	645	2	9	CARDINAL
ijpds-4564	645	3	798147 87	DATE
ijpds-4564	646	1	dugarte-dugarte aj	PERSON
ijpds-4564	646	2	toro	ORG
ijpds-4564	646	3	van de streek j	ORG
ijpds-4564	648	1	antiparkinsonian	NORP
ijpds-4564	648	2	r)-rasagiline	NORP
ijpds-4564	649	1	sci cryst eng	ORG
ijpds-4564	650	1	2023	CARDINAL
ijpds-4564	650	2	79(6):462–72	CARDINAL
ijpds-4564	651	1	saralaya ss	PERSON
ijpds-4564	652	1	indian	NORP
ijpds-4564	652	2	2024	CARDINAL
ijpds-4564	652	3	3(2):46-56	DATE